A. Begg

发表

Predicting outcomes in radiation oncology—multifactorial decision support systems

P. Lambin, M. Starmans, P. Boutros, 2013, Nature Reviews Clinical Oncology.

The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts.

A. Begg, K. Dittmann, N. Gueven, 1998, Radiation research.

5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.

K. Haustermans, A. Begg, W. McBride, 2011, International journal of radiation oncology, biology, physics.

Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.

C. Perneel, A. Debucquoy, K. Haustermans, 2006, International journal of radiation oncology, biology, physics.

Strategies to improve radiotherapy with targeted drugs

Fiona A. Stewart, Conchita Vens, F. Stewart, 2011, Nature Reviews Cancer.

Towards genetic prediction of radiation responses: ESTRO's GENEPI project.

Michael Baumann, Tobias Hölscher, M. Baumann, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.

Jacques Bernier, Michel Bolla, Laurence Collette, 1997, Radiotherapy and Oncology.

The Incidence of Lung Metastases in C3h Mice after Treatment of Implanted Solid Tumours with X-rays or Surgery

J. Fowler, A. Begg, P. Sheldon, 1974, British Journal of Cancer.

Predicting response to radiotherapy: Evolutions and revolutions

A. Begg, 2009, International journal of radiation biology.

Towards prediction and modulation of treatment response.

H. Bartelink, L. J. van 't Veer, A. Begg, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of fluorescence in situ hybridization to measure chromosome aberrations as a predictor of radiosensitivity in human tumour cells.

H. Bartelink, A. Begg, M. Smeets, 1994, International journal of radiation biology.

Investigation of possible endogenous hypoxia markers in colorectal cancer

A. Debucquoy, K. Haustermans, A. Begg, 2013, International journal of radiation biology.

Fluorescent markers of hypoxic cells: a comparison of two compounds on three cell lines.

A. Begg, N. J. McNally, M. Stratford, 1985, The British journal of radiology.

Nitroakridin 3582: a fluorescent nitroacridine stain for identifying hypoxic cells.

A. Begg, N. J. McNally, P. Wardman, 1983, The British journal of radiology.

Radiation-induced DNA damage and repair in radiosensitive and radioresistant human tumour cells measured by field inversion gel electrophoresis.

A. Begg, M. Smeets, E. Mooren, 1993, International journal of radiation biology.

Radiosensitization by cisplatin of RIF1 tumour cells in vitro.

H. Bartelink, A. Begg, L. Dewit, 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

A bioassay for cyclophosphamide in blood, lung and tumour.

A. Begg, K. Smith, 1984, British Journal of Cancer.

Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro.

M. Ruevekamp, J. Schornagel, A. Begg, 1994, Cancer research.

Clinical radiobiology in 2008.

A. Begg, A. J. van der Kogel, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prediction of treatment outcome by cisplatin‐DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin‐radiation (RADPLAT)

H. Bartelink, F. Hoebers, J. Schellens, 2006, International journal of cancer.

Oral platinum analogue JM216, a radiosensitizer in oxic murine cells.

A. Begg, I. Hofland, P. van de Vaart, 1997, International journal of radiation biology.

Improvement of combined modality therapy with cisplatin and radiation using intratumoral drug administration in murine tumors.

H. Bartelink, A. Begg, W. Kop, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The effect of cisplatin on the repair of radiation damage in RIF1 mouse tumours in vivo.

H. Bartelink, A. Begg, S. Bohlken, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined Treatment with Radiation and Anti-Cancer Drugs: Experimental and Clinical Results

H. Bartelink, F. Stewart, A. Begg, 1988 .

Radiosensitization of Squamous Cell Carcinoma by the Alkylphospholipid Perifosine in Cell Culture and Xenografts

J. Schellens, A. Begg, M. Verheij, 2006, Clinical Cancer Research.

HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors

G. Semenza, F. Hoebers, K. Haustermans, 2002 .

Hypoxic cell turnover in different solid tumor lines.

J. Bussink, A. Begg, J. Kaanders, 2005, International journal of radiation oncology, biology, physics.

Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.

A. Begg, B. Floot, L. den Engelse, 1987, Cancer research.

The effect of radiation on G2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities.

A. Begg, M. Smeets, E. Mooren, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia The autophagy associated gene , ULK 1 , promotes tolerance to chronic and acute hypoxia

M. Starmans, J. Bussink, B. Wouters, 2013 .

The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia.

M. Starmans, J. Bussink, B. Wouters, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1.

V. Grégoire, K. Haustermans, P. Mahy, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.

R. Sciot, A. Begg, M. Varia, 2001, Acta oncologica.

IS SELECTION THE KEY TO SUCCESS IN COMBINING RADIOTHERAPY AND CHEMOTHERAPY

H. Bartelink, F. Stewart, A. Begg, 1992 .

Modification of stromal radiosensitivity by misonidazole and WR-2721.

A. Begg, N. Terry, 1983, The British journal of radiology.

Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.

A. Begg, I. Hofland, M. Sund, 1993, British Journal of Cancer.

Defective repair of DNA double-strand breaks and chromosome damage in fibroblasts from a radiosensitive leukemia patient.

R. Okayasu, A. Begg, C. Badie, 1995, Cancer research.

Labelling indices in human tumours: to apply corrections or not – that is the question

A. Waites, A. Begg, J. Denekamp, 1999, British Journal of Cancer.

Key wordy: Cell kinetics; Human tumours: Iododeoxyuridinc: Flow cytometry; Monoclonal antibodies

A. Begg, A. Leeuwenhoekhuis, 1988 .

Cell Cycle Kinetics of Aerated, Hypoxic and Re‐Aerated Cells In Vitro Using Flow Cytometric Determination of Cellular Dna and Incorporated Bromodeoxyuridine

D. Shrieve, A. Begg, A. Begg, 1985, Cell and tissue kinetics.

Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest

P. Jeggo, A. Waugh, A. Begg, 2002, Oncogene.

Re-oxygenation of tumours after irradiation and cell population kinetics.

A. Begg, J. Denekamp, A. Howes, 1969, The Journal of physiology.

Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.

A. Hart, A. Begg, B. Floot, 1988, Cancer research.

The effects of misonidazole during continuous low dose rate irradiation.

K. Fu, A. Begg, J. Brown, 1980, Cancer clinical trials.

Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels above 120 G/DL with Erythropoietin vs above 100 G/DL without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer: A Gynecologic Oncology Group Study

F. Hoebers, A. Begg, Shamshad Ali, 2008 .

Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotides

A. Begg, O. Tellingen, B. Floot, 2004, Cancer Chemotherapy and Pharmacology.

Formation of interaction products of carboplatin with DNA in vitro and in cancer patients.

A. Begg, B. Floot, L. den Engelse, 1991, British Journal of Cancer.

Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.

A. Begg, P. Schrier, B. Floot, 1990, Cancer research.

Cisplatin and radiation: interaction probabilities and therapeutic possibilities.

A. Begg, 1990, International journal of radiation oncology, biology, physics.

Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40).

H. Bartelink, A. Begg, P. J. van der Kolk, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effects of hypoxia, pH, and growth stage on cell killing in Chinese hamster V79 cells in vitro by activated cyclophosphamide.

D. Shrieve, A. Begg, K. Smith, 1985, Cancer research.

Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice.

J. Fowler, A. Begg, S. Hill, 1975, International journal of radiation biology and related studies in physics, chemistry, and medicine.

The effects of combined bleomycin and irradiation on a solid murine tumor.

K. Fu, T. Phillips, A. Begg, 1979, International journal of radiation oncology, biology, physics.

Combination therapy of a solid murine tumor with cyclophosphamide and radiation: the effects of time, dose and assay method.

K. Fu, T. Phillips, D. Shrieve, 1979, International journal of radiation oncology, biology, physics.

Renal damage in mice after treatment with cisplatin and x-rays: comparison of fractionated and single-dose studies.

H. Bartelink, F. Stewart, A. Begg, 1988, NCI monographs : a publication of the National Cancer Institute.

[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].

J. Horiot, M. Piérart, M. van Glabbeke, 1996, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

Do Cancer esearch apeutics , Targets , and Chemical

A. Begg, M. Verwijs-Janssen, Lenie J. van den Broek, 2010 .

Cancer esearch apeutics , Targets , and Chemical

A. Begg, M. Verwijs-Janssen, Lenie J. van den Broek, 2010 .

321 Hyperfractionated (HF) and accelerated (AF) radiotherapy (RT) in head and neck cancers: Facts from trials, impact on standard practice

J. Horiot, M. Piérart, M. Glabbeke, 1995 .

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.

A. C. Begg, A. Begg, J. Denekamp, 1988, British Journal of Cancer.

Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding.

G. Wilson, A. Begg, M. Stratford, 1991, Biochemical pharmacology.

Intratumoural administration of cisplatin in slow-release devices

H. Bartelink, W. Hennink, A. Begg, 1990, Cancer Chemotherapy and Pharmacology.

Intratumoural administration of cisplatin in slow-release devices: II. pharmacokinetics and intratumoural distribution

H. Bartelink, A. Begg, O. Tellingen, 2004, Cancer Chemotherapy and Pharmacology.

Effects of hyperthermia and X-irradiation on mouse stromal tissue.

J. Wondergem, J. Haveman, A. Begg, 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Rapid fluorescence-based assay for radiosensitivity and chemosensitivity testing in mammalian cells in vitro.

A. Begg, E. Mooren, 1989, Cancer research.

Prediction of repopulation rates and radiosensitivity in human tumours.

A. Begg, 1994, International journal of radiation biology.

Status of the experience of the EORTC cooperative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes

J. Horiot, M. Piérart, S. Schraub, 1992 .

Tolerance of previously irradiated mouse kidneys to cis-diamminedichloroplatinum(II).

F. Stewart, A. Begg, A. Luts, 1987, Cancer research.

Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer.

A. Hart, H. Bartelink, A. Begg, 1998, International journal of radiation biology.

Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.

H. Bartelink, V. Grégoire, A. Begg, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of cis-diamminedichloroplatinum (II) on mouse duodenal crypt stem cell survival after multifraction X ray treatment.

H. Bartelink, F. Stewart, A. Begg, 1985, International journal of radiation oncology, biology, physics.

CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

F. Hoebers, E. Schuuring, C. Rasch, 2010, Clinical Cancer Research.

Additivity versus repair inhibition in fractionated treatments combining drugs and X rays: a theoretical analysis.

A. Begg, 1987, International journal of radiation oncology, biology, physics.

Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy.

A. Hart, J. Lebesque, A. Begg, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Detection of radiation-induced chromosome aberrations using fluorescence in situ hybridization in drug-induced premature chromosome condensations of tumour cell lines with different radiosensitivities.

A. Begg, J. Coco-Martin, 1997, International journal of radiation biology.

A comprehensive PC-based computer model for microdosimetry of BNCT.

A. Begg, R. Verrijk, F. Wheeler, 1994, International journal of radiation biology.

KINETIC AND HISTOLOGICAL CHANGES OF A SERIALLY TRANSPLANTED MOUSE TUMOUR

A. Begg, A. Begg, 1971, Cell and tissue kinetics.

The role of DNA polymerase beta in determining sensitivity to ionizing radiation in human tumor cells

Conchita Vens, Els Dahmen-Mooren, Manon Verwijs-Janssen, 2002, Nucleic Acids Res..

Rapid Fluorescence Ratio Assay for Detecting Changes in Radiosensitivity

A. Begg, I. Hofland, C. Vens, 2002, Radiation research.

Involvement of DNA Polymerase Beta in Repair of Ionizing Radiation Damage as Measured by In Vitro Plasmid Assays

A. Begg, I. Hofland, C. Vens, 2007, Radiation research.

Genetic manipulation of radiosensitivity.

A. Begg, C. Vens, 2001, International journal of radiation oncology, biology, physics.

The sensitivity of normal stroma to fractionated radiotherapy measured by a tumour growth rate assay.

A. Begg, N. Terry, 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}.

Lenie J. van den Broek, A. Begg, C. Vens, 2010, Cancer research.

Targeting base excision repair as a sensitization strategy in radiotherapy.

A. Begg, C. Vens, 2010, Seminars in radiation oncology.

Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta.

A. Begg, E. Dikomey, C. Vens, 2009, DNA repair.

Role for DNA polymerase beta in response to ionizing radiation.

A. Begg, P. Cramers, C. Vens, 2007, DNA repair.

Radiosensitization by a dominant negative to DNA polymerase β is DNA polymerase β-independent and XRCC1-dependent

A. Begg, C. Vens, S. Neijenhuis, 2005 .

Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent.

A. Begg, C. Vens, S. Neijenhuis, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report.

H. Bartelink, J. Horiot, M. van Glabbeke, 1990, International journal of radiation oncology, biology, physics.

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

D. Shrieve, A. Begg, N. J. McNally, 1985, Cytometry.

7.03 – Molecular Radiation Biology

A. Begg, 2014 .

Predicting recurrence after radiotherapy in head and neck cancer.

A. Begg, 2012, Seminars in radiation oncology.

Intrinsic radiosensitivity and chromosome aberration analysis using fluorescence in situ hybridization in cells of two human tumor cell lines.

P. Lambin, A. Begg, C. Parmentier, 1994, Radiation research.

Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients

L. Wessels, A. Begg, M. Verheij, 2015, Clinical Cancer Research.

Potential of radiation-induced chromosome aberrations to predict radiosensitivity in human tumour cells.

H. Bartelink, W. Burrill, A. Begg, 1999, International journal of radiation biology.

Lethality of radiation-induced chromosome aberrations in human tumour cell lines with different radiosensitivities.

H. Bartelink, A. Begg, J. Coco-Martin, 1996, International journal of radiation biology.

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation

A. Begg, G. Wilson, H. Awwad, 2002, British Journal of Cancer.

Radiation-induced differentiation of human skin fibroblasts: relationship with cell survival and collagen production.

H. Bartelink, A. Begg, P. Lara, 1996, International journal of radiation biology.

Radiobiology: State of the present art. A conference report

A. Begg, 2010, International Journal of Radiation Biology.

J. Horiot, M. Piérart, L. Collette, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Differences in chemosensitivity between subcutaneous and pulmonary tumours.

A. Begg, J. Denekamp, K. Smith, 1985, European journal of cancer & clinical oncology.

Differential repair of radiation-induced DNA damage in cells of human squamous cell carcinoma and the effect of caffeine and cysteamine on induction and repair of DNA double-strand breaks.

H. Bartelink, A. Begg, M. Smeets, 1994, Radiation research.

Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.

H. Bartelink, J. Beijnen, A. Begg, 1998, European journal of cancer.

Impact of supervised gene signatures of early hypoxia on patient survival.

Glenn Fung, Balaji Krishnapuram, Philippe Lambin, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours.

S B Field, J F Fowler, J. Fowler, 1972, The British journal of radiology.

Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival.

K. Fu, T. Phillips, A. Begg, 1980, Cancer research.

Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin‐based chemoradiation

P. V. van Diest, E. Schuuring, L. Looijenga, 2009, International journal of cancer.

Stromal damage as a complication in the interpretation of tumour growth delay.

A. Begg, J. Denekamp, A C Begg, 1983, European journal of cancer & clinical oncology.

Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating.

K. Haustermans, A. Begg, A. Balm, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy.

J. Lebesque, A. Begg, N. Russell, 1993, International journal of radiation biology.

Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains.

H. Bartelink, A. Begg, C. Arlett, 1995, International journal of radiation biology.

A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.

David Boulware, Ji-Hyun Lee, T. Yeatman, 2009, International journal of radiation oncology, biology, physics.

Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.

K. Haustermans, A. Begg, M. Varia, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Optimum fractionation in X-ray treatment of C3H mouse mammary tumours.

J. Fowler, A. Begg, J. Denekamp, 1974, The British journal of radiology.

Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status.

A. Begg, H. Janssen, C. Vens, 2006, International journal of radiation oncology, biology, physics.

Hypoxia in head and neck cancer: How much, how important?

K. Haustermans, A. Begg, A C Begg, 2005, Head & neck.

Premature chromosome condensation and cell separation studies in biopsies from head and neck tumors for radiosensitivity prediction.

A. Begg, A. Balm, D. Sprong, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

F. Hoebers, E. Schuuring, C. Rasch, 2010, Clinical Cancer Research.

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

H. Bartelink, F. Hoebers, L. Stalpers, 2007, Cancer Chemotherapy and Pharmacology.

Stromal radiosensitivity: influence of tumour type on the Tumour Bed Effect assay.

A. Begg, N. Terry, 1985, The British journal of radiology.

Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system.

D. M. Brown, H. Bartelink, F. Stewart, 1988, NCI monographs : a publication of the National Cancer Institute.

In vivo bromodeoxyuridine labelling in human tumour xenografts.

A. Begg, G. Steel, P. Price, 1989, International journal of radiation biology.

Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage.

A. Begg, N. Russell, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.

Frank J P Hoebers, D. Atsma, F. Hoebers, 2007, International journal of radiation oncology, biology, physics.

Establishment of a Radiogenomics Consortium.

Andrzej Polanski, Karin Haustermans, Barry Rosenstein, 2010, International journal of radiation oncology, biology, physics.

Translational research offers individually tailored treatments for cancer patients.

H. Bartelink, A. Begg, L. Moonen, 2000, The cancer journal from Scientific American.

Letter: A rapid method for the determination of tumour RBE.

J. Fowler, A. Begg, 1974, The British journal of radiology.

The interaction of radiation and bleomycin in intestinal crypt cells.

T. Phillips, A. Begg, L. Goldstein, 1979, International journal of radiation oncology, biology, physics.

Use of thymidine analogues to indicate vascular perfusion in tumours

K. Haustermans, A. Begg, I. Hofland, 2000, British Journal of Cancer.

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer.

F. Hoebers, A. Begg, Shamshad Ali, 2008, Gynecologic oncology.

Ionizing Radiation Sensitivity of DNA Polymerase Lambda-Deficient Cells

B. Bertocci, A. Begg, C. Vens, 2007, Radiation research.

Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21

F. Hoebers, K. Haustermans, A. Nunn, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

DNA‐adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

H. Bartelink, D. de Jong, A. Begg, 2000, International journal of cancer.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

J C Horiot, A. Hart, H. Bartelink, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Repair of sublethal radiation injury after multiple small doses in mouse kidney: an estimate of flexure dose.

H. Bartelink, F. Stewart, J. Lebesque, 1987, International journal of radiation oncology, biology, physics.

Cell kinetic measurements in prostate cancer.

R Oyen, J F Fowler, J. Fowler, 1997, International journal of radiation oncology, biology, physics.

Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting.

Michael Baumann, Karin Haustermans, Jolyon H Hendry, 2005, International journal of radiation oncology, biology, physics.

HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors.

M. Hauptmann, C. Rasch, A. Begg, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients.

A. Hart, H. Bartelink, A. Begg, 2000, International journal of radiation biology.

Heterogeneity of gene expression profiles in head and neck cancer

D. Atsma, M. V. van Velthuysen, A. Begg, 2007, Head & neck.

Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.

H. Bartelink, A. Begg, L. Moonen, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictive Value of Potential Doubling Time for Radiotherapy of Head and Neck Tumor Patients: Results from the EORTC Cooperative Trial 22851

Harry Bartelink, H. Bartelink, J. Horiot, 1992 .

Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.

A. Begg, I. Hofland, J. Kummermehr, 1991, European journal of cancer.

Thymidine analogues to assess microperfusion in human tumors.

J. Bussink, K. Haustermans, A. Begg, 2005, International journal of radiation oncology, biology, physics.

Visualization of Cisplatin-DNA and Carboplatin-DNA Adducts in Tissues and Cultured Cells

A. Begg, B. Floot, L. Engelse, 1988 .

Cisplatin-Radiation Interactions in Tumours and Normal Tissues

H. Bartelink, F. Stewart, A. Begg, 1988 .

Radiobiology Studies at Petten: Status on Cell Culture, Mice and Dog Experiments

V. Grégoire, A. Begg, R. Verrijk, 1992 .

Comparative Pharmacokinetics and Distribution Studies of Boric Acid, L-BPA and BSH in Two Murine Tumour Models

V. Grégoire, A. Begg, R. Verrijk, 1992 .

The clinical status of Tpot as a predictor? Or why no tempest in the Tpot!

A. Begg, A C Begg, 1995, International journal of radiation oncology, biology, physics.

Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study.

K. Haustermans, A. Begg, I. Hofland, 1995, Cytometry.

Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.

A. Begg, I. Hofland, 1991, Cytometry.

Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma.

J. Horiot, M. Piérart, M. van Glabbeke, 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Ploidy status and the response of T1 glottic carcinoma to radiotherapy.

F. Hilgers, A. Begg, W. Mooi, 1993, Clinical otolaryngology and allied sciences.

Analysis of growth delay data: potential pitfalls.

A. Begg, A C Begg, 1980, The British journal of cancer. Supplement.

Is HIF-1α a good marker for tumor hypoxia?

A. Begg, 2003 .

Cell cycle phase dependent role of DNA polymerase beta in DNA repair and survival after ionizing radiation.

A. Begg, C. Vens, C. Vermeulen, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A PC-Based Computer Program for the Estimation of the Radiation Dose in in Vitro and in Vivo Boron Neutron Capture Irradiation Experiments

A. Begg, R. Verrijk, R. Huiskamp, 1993 .

BASIC SCIENCE REVIEW

K. Haustermans, R. Ferris, A. Begg, 2005 .

HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.

G. Semenza, F. Hoebers, K. Haustermans, 2002, International journal of radiation oncology, biology, physics.

A bioassay for cyclophosphamide in blood, lung and tumour.

A. Begg, K. Smith, 1984, British Journal of Cancer.

Combination therapy of a solid murine tumor with 1, 3 bis (2-chloroethyl)-1-nitrosourea and irradiation.

K. Fu, T. Phillips, A. Begg, 1979, International journal of radiation oncology, biology, physics.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

A. Hart, H. Bartelink, J. Horiot, 1999, Radiotherapy and Oncology.